Phortas

Phortas is a consultancy firm specializing in regulatory affairs, clinical management and drug development. It supports organizations as they develop medicines and related products, helping them access relevant expertise and address development requirements. Its services are available for drugs, biologics, combination products and medical devices, including specialty medicines such as orphan and pediatric medicines, advanced therapy medicinal products (ATMPs) and repurposed medicines.

Phortas works with small and medium-sized businesses, biotechnology and pharmaceutical companies, contract research organizations, and academic institutions. Its experience spans therapeutic areas including oncology, central nervous system disorders, neuromuscular conditions, nephrology, inflammation, ophthalmology, immunology, respiratory diseases, dermatology, haematology and cardiology.

The firm emphasizes experienced professionals, responsive project support and flexible engagement. Clients can seek help through ad hoc, short-term or long-term projects, with support structured to address their needs. Phortas also assists clients in interacting with regulatory authorities in Europe and the United States. Its website features case studies, a blog and information about its services, alongside contact details for organizations seeking consulting support.